Surgery Center Tokenization: A $40B Care Asset

The U.S. ambulatory surgery center market was valued near $40 billion in 2024 and is projected by Grand View Research to keep growing through the decade as procedures migrate out of hospitals into lower-cost outpatient settings. More than 6,000 Medicare-certified ambulatory surgery centers now operate nationwide, performing tens of millions of procedures a year. That combination — recurring clinical revenue, durable demand, and fragmented ownership — is exactly what institutional real-asset allocators look for, yet the equity has remained largely closed. Surgery center tokenization is the structure beginning to open it.

What Surgery Center Tokenization Means

An ambulatory surgery center, or ASC, is two assets in one: the medical real estate and the operating business that runs inside it. Tokenization works on the ownership interest and the cash flow, not the operating rooms themselves. A tokenized surgery center position is a regulated security — typically a Reg D, Reg S, or Reg A+ instrument — representing fractional economic interest in the operating entity, the underlying property, or a defined revenue stream tied to a specific center or portfolio.

The economics separate into layers with different risk profiles. The real estate layer — the building and land, often held under a long-term net lease to the operating ASC — behaves like specialized medical real estate with sticky tenancy. The operating layer captures facility fees, the per-procedure charges that drive most ASC revenue, and carries reimbursement and volume risk. Many centers also sit under physician-ownership or joint-venture structures with a hospital system, which shapes how cash flow and governance are split.

The token is the legal wrapper. The underlying is a building, a clinical operating entity, and a stack of payer and physician agreements. Tokenization does not change the economics of a busy orthopedic surgery center — it changes how the position settles, how it reports, who can hold it, and whether a qualified investor can exit before a long hold matures. The mechanics are the same ones described in our overview of how tokenization works.

Why Outpatient Care Cash Flows Attract Institutional Capital

Ambulatory surgery has been one of the clearest structural shifts in U.S. healthcare, and several characteristics explain why allocators are paying attention.

The first is the migration of volume. Procedures that once required a hospital stay — joint replacements, spine work, cardiology, ophthalmology — are moving to outpatient settings as clinical techniques and payer policy evolve. The Centers for Medicare & Medicaid Services has steadily expanded the list of procedures reimbursable in an ASC, and commercial payers favor the setting because it costs less. That policy tailwind supports volume growth across the sector, a dynamic detailed in healthcare-investment research from firms including Bain & Company.

The second is recurring, demographically backed demand. An aging population drives surgical volume that does not move with the economic cycle the way discretionary spending does. A center anchored by a stable physician panel produces predictable, repeat procedure revenue, giving the income a resilience that many commercial property types lack.

The third is the access and consolidation gap. ASC ownership is fragmented across physician groups, hospital joint ventures, and management companies, with consolidation still well underway. A family office, private credit firm, or insurance allocator has had almost no practical route into stabilized outpatient-care cash flow at fractional scale. Tokenized issuance widens the investor base without forcing a sale of the whole center or a traditional fund-formation cycle. Positions structured this way can sit alongside other healthcare real-asset offerings, including those covered in our analysis of medical office building tokenization.

How the Capital Structure Works

In institutional structures, the underlying surgery center interest is held in a special-purpose vehicle, and the token represents pro-rata equity, preferred interest, or a defined claim on a contracted revenue line within that SPV.

A real-estate structure isolates the building, held under a net lease to the operating ASC, and tokenizes it as a medical-real-estate income instrument — the most conservative layer, with reimbursement risk sitting one step removed at the tenant. A single-center operating structure tokenizes equity or preferred interest in the operating entity, capturing facility-fee revenue with the volume and payer exposure that comes with it. A portfolio structure groups several centers — often across specialties and regions to diversify procedure mix and payer concentration — into a single tokenized vehicle that behaves like a private healthcare-real-asset fund interest.

None of these structures changes the underlying leases, payer contracts, or physician agreements. What changes is who can hold the position, how it settles, and whether a qualified investor can transfer out before a long hold matures. Compliant secondary venues operating under Reg ATS frameworks let qualified holders move positions without forcing the sponsor to manage redemptions, which compresses the liquidity discount institutional buyers apply to locked-up real estate. The rights the token carries are governed by the token framework the issuer adopts.

Compliance for a Tokenized Surgery Center

The regulatory posture for a surgery center token is the posture of any institutional private placement, with two additional layers: the digital-instrument requirements and the heavy healthcare-specific regulation that governs ASCs.

The instrument has to be classified correctly under federal and state securities law. In U.S. structures, a tokenized ASC interest is a security, which dictates investor eligibility — accredited, qualified purchaser, or qualified institutional buyer — and sets transfer restrictions, holding periods, and reporting obligations. Investor onboarding has to handle KYC, AML, accreditation, and sanctions screening at the protocol level, with transfer restrictions enforced on-chain so a token cannot move to a wallet that has not cleared review. Most retail-oriented tokenization infrastructure cannot meet that bar without heavy retrofitting, which is why institutional issuance runs on compliance-first platforms built for regulated instruments.

The healthcare layer is where ASC tokenization is genuinely distinct. Physician self-referral rules under the federal Stark Law and the Anti-Kickback Statute govern who may hold an economic interest in a center and how that interest relates to the referral of patients. A token structure cannot be used to put a prohibited investor into the cash flow, and the offering documents must be explicit about ownership eligibility, the role of physician-owners, and any hospital joint-venture terms. State certificate-of-need rules and licensure requirements add further constraints on transfer and control. This is a sector where the legal structure has to lead the token, not the other way around.

What Allocators Should Underwrite

Tokenization does not replace real-asset diligence — it adds to it.

The underlying asset still has to clear traditional underwriting: procedure mix and case volume, payer mix and reimbursement exposure, the depth and loyalty of the physician panel, the credit of the operating tenant, and the regulatory standing of the center. A tokenized stake in a center with declining volume or a concentrated, aging physician panel is still a weak asset, and the wrapper does not improve the case schedule.

The token structure has to be legally clean, and in this sector that bar is higher than usual. Who holds the real estate versus the operating entity? How do token-holder rights interact with Stark, Anti-Kickback, and state licensure constraints? What is the dispute-resolution path if a transfer is contested or a physician-owner exits? These belong in the offering documents, not in assumptions.

Finally, the operational layer has to be institutional. A pension or insurance allocator needs audited NAV, capital-account statements, and reporting an auditor can sign, plus custody that integrates with qualified custodians and fund administrators. The income is recurring and demographically backed, the sector is fragmented and historically closed, and surgery center tokenization is the structure widening the door for institutional capital — provided the healthcare compliance is built in from the start.

Have an asset you're evaluating for tokenization? Send the offering memo to deals@commertize.com or start at commertize.com/tokenize, and we will return a written tokenizability and capital-structure memo within 48 hours — free, no obligation.

Confidential review. No cost, no commitment, no calls unless it is a fit.